343 related articles for article (PubMed ID: 28859399)
1. Microvesicles released during the interaction between Trypanosoma cruzi TcI and TcII strains and host blood cells inhibit complement system and increase the infectivity of metacyclic forms of host cells in a strain-independent process.
Wyllie MP; Ramirez MI
Pathog Dis; 2017 Sep; 75(7):. PubMed ID: 28859399
[TBL] [Abstract][Full Text] [Related]
2. Dynamic flux of microvesicles modulate parasite-host cell interaction of Trypanosoma cruzi in eukaryotic cells.
Ramirez MI; Deolindo P; de Messias-Reason IJ; Arigi EA; Choi H; Almeida IC; Evans-Osses I
Cell Microbiol; 2017 Apr; 19(4):. PubMed ID: 27665486
[TBL] [Abstract][Full Text] [Related]
3. Complement system contributes to modulate the infectivity of susceptible TcI strains of Trypanosoma cruzi.
Arroyo-Olarte RD; Martínez I; Cruz-Rivera M; Mendlovic F; Espinoza B
Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170332. PubMed ID: 29513875
[TBL] [Abstract][Full Text] [Related]
4. Differential ability to resist to complement lysis and invade host cells mediated by MBL in R4 and 860 strains of Trypanosoma cruzi.
Evans-Osses I; Mojoli A; Beltrame MH; da Costa DE; DaRocha WD; Velavan TP; de Messias-Reason I; Ramirez MI
FEBS Lett; 2014 Mar; 588(6):956-61. PubMed ID: 24560788
[TBL] [Abstract][Full Text] [Related]
5. Host cell invasion and oral infection by Trypanosoma cruzi strains of genetic groups TcI and TcIV from chagasic patients.
Maeda FY; Clemente TM; Macedo S; Cortez C; Yoshida N
Parasit Vectors; 2016 Apr; 9():189. PubMed ID: 27038796
[TBL] [Abstract][Full Text] [Related]
6. Invasion of MDCK epithelial cells with altered expression of Rho GTPases by Trypanosoma cruzi amastigotes and metacyclic trypomastigotes of strains from the two major phylogenetic lineages.
Fernandes AB; Mortara RA
Microbes Infect; 2004 Apr; 6(5):460-7. PubMed ID: 15109960
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles Shed By
Lovo-Martins MI; Malvezi AD; Zanluqui NG; Lucchetti BFC; Tatakihara VLH; Mörking PA; de Oliveira AG; Goldenberg S; Wowk PF; Pinge-Filho P
Front Immunol; 2018; 9():896. PubMed ID: 29755471
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles.
Cestari I; Ansa-Addo E; Deolindo P; Inal JM; Ramirez MI
J Immunol; 2012 Feb; 188(4):1942-52. PubMed ID: 22262654
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Infectivity and Evasion Derived from Microvesicles Cargo Produced by
Borges BC; Uehara IA; Dias LO; Brígido PC; da Silva CV; Silva MJ
Front Cell Infect Microbiol; 2016; 6():161. PubMed ID: 27921011
[TBL] [Abstract][Full Text] [Related]
10. Mexican Trypanosoma cruzi isolates: in vitro susceptibility of epimastigotes to anti-trypanosoma cruzi drugs and metacyclic forms to complement-mediated lysis.
León-Pérez F; Gómez-Garcia L; Alejandre-Aguilar R; López R; Monteón VM
Vector Borne Zoonotic Dis; 2007; 7(3):330-6. PubMed ID: 17760512
[TBL] [Abstract][Full Text] [Related]
11.
Ramírez-Toloza G; Ferreira A
Front Microbiol; 2017; 8():1667. PubMed ID: 28919885
[TBL] [Abstract][Full Text] [Related]
12. Cell invasion by Trypanosoma cruzi amastigotes of distinct infectivities: studies on signaling pathways.
Fernandes AB; Neira I; Ferreira AT; Mortara RA
Parasitol Res; 2006 Dec; 100(1):59-68. PubMed ID: 16791632
[TBL] [Abstract][Full Text] [Related]
13. Mammalian cell invasion by closely related Trypanosoma species T. dionisii and T. cruzi.
Maeda FY; Cortez C; Alves RM; Yoshida N
Acta Trop; 2012 Feb; 121(2):141-7. PubMed ID: 22079376
[TBL] [Abstract][Full Text] [Related]
14. Novel strategy in Trypanosoma cruzi cell invasion: implication of cholesterol and host cell microdomains.
Fernandes MC; Cortez M; Geraldo Yoneyama KA; Straus AH; Yoshida N; Mortara RA
Int J Parasitol; 2007 Nov; 37(13):1431-41. PubMed ID: 17582418
[TBL] [Abstract][Full Text] [Related]
15. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
Sher A; Hieny S; Joiner K
J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
[TBL] [Abstract][Full Text] [Related]
16. An induced population of
Rossi IV; Nunes MAF; Sabatke B; Ribas HT; Winnischofer SMB; Ramos ASP; Inal JM; Ramirez MI
Front Cell Infect Microbiol; 2022; 12():1046681. PubMed ID: 36590580
[TBL] [Abstract][Full Text] [Related]
17. Purification of Trypanosoma cruzi metacyclic trypomastigotes by ion exchange chromatography in sepharose-DEAE, a novel methodology for host-pathogen interaction studies.
Cruz-Saavedra L; Muñoz M; León C; Patarroyo MA; Arevalo G; Pavia P; Vallejo G; Carranza JC; Ramírez JD
J Microbiol Methods; 2017 Nov; 142():27-32. PubMed ID: 28865682
[TBL] [Abstract][Full Text] [Related]
18. The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence.
Ramírez-Toloza G; Aguilar-Guzmán L; Valck C; Ferreira VP; Ferreira A
Front Immunol; 2020; 11():1561. PubMed ID: 32793217
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
Yoshida N
Parasitol Int; 2008 Jun; 57(2):105-9. PubMed ID: 18234547
[TBL] [Abstract][Full Text] [Related]
20. Differential gene expression of virulence factors modulates infectivity of TcI Trypanosoma cruzi strains.
Arroyo-Olarte RD; Martínez I; Lujan E; Mendlovic F; Dinkova T; Espinoza B
Parasitol Res; 2020 Nov; 119(11):3803-3815. PubMed ID: 33006041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]